Ongoing Projects

Ongoing Projects:

1. Lebecetin: Novel Biopharmaceutical for non-responder nAMD and DR patients, IFCPAR (CEFIPRA), India Habitat Centre, India, 73.7 Lakhs, Sep 2024, 2 years.

2. Consortia for vaccine candidate development against arboviruses, ICMR, 4.6 Crores, June 2024, 5 years.

3. Platform for reliable characterization and evaluation of comparability of biosimilar drug products in lyophilized and liquid formulations, US FDA, 6.6 Crores, Sep 2022, 3 years

4. Creating as Continuous Process Platform for Production of Biotherapeutic Products, Pall Life Science, 1.8 Crores, Sep 2022, 3 years

5. Modulation of protein aggregation by excipients designed with high specificity for misfolded states, SERB DST, 50 Lakhs, May 2023, 3 years.

6. Spectroscopy based characterization of cell culture samples, Enzene Biosciences Limited, 50 Lakhs, Nov 2024.

7. Stability of high concentration formulations, Generate Biomedicines, 2 Crores, Apr 2024